UMDNJ Scleroderma Program — New Brunswick, New Jersey

UMDNJ Scleroderma Program is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

UMDNJ Scleroderma Program has participated in 1 clinical trials.

Therapeutic areas: Systemic Sclerosis, Scleroderma.

Sponsors: Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UMDNJ Scleroderma Program?

UMDNJ Scleroderma Program has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UMDNJ Scleroderma Program conducted?

UMDNJ Scleroderma Program has 1 clinical trials on record. Their work covers Systemic Sclerosis, Scleroderma.

Is UMDNJ Scleroderma Program accredited by Crixeo Health?

UMDNJ Scleroderma Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UMDNJ Scleroderma Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.